Salix Pharmaceuticals
Raleigh, US
Founders & leadership
WP
William P. ForbesExecutive
CJ
Carolyn J. LoganinExecutive
AC
Adam C. DerbyshireinCFOformer
RD
Rick D. ScruggsinEVP Business Developmentformer
Board
TW
Thomas W. D'AlonzoBoard director
JF
John F. ChappellBoard director
MA
Mark A. SirgoBoard director
WP
William P. KeaneBoard director
Reported raises · per SEC filings
Form D private placements$750M disclosed across 1 round · 2013
▶$750MraisedJan 2014 · 7 investors · PharmaceuticalsRule 506(b)
▶$750MraisedJan 2014 · 7 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas W. D'AlonzoDirector
- William P. ForbesExecutive Officer
- John F. ChappellDirector
- Mark A. SirgoDirector
- William P. KeaneDirector
- Carolyn J. LoganExecutive Officer, Director
- Adam C. DerbyshireExecutive Officer
- Rick D. ScruggsExecutive Officer
- Offering amount
- $750M
- Amount sold
- $750M
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Salix Pharmaceuticals raised?
- Salix Pharmaceuticals has disclosed $750M raised across 1 round.
- Where is Salix Pharmaceuticals headquartered?
- Salix Pharmaceuticals is headquartered in Raleigh, US.